iohexol has been researched along with Hypertriglyceridemia in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Proteinuria was in the nephrotic range in 44 and the BMI exceeded the 95th percentile in 57 patients of this cohort." | 1.36 | Dyslipidemia in children with chronic kidney disease. ( Flynn, JT; Furth, SL; Goebel, J; Kupferman, JC; Mitsnefes, MM; Pierce, CB; Saland, JM; Warady, BA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saland, JM | 1 |
| Pierce, CB | 1 |
| Mitsnefes, MM | 1 |
| Flynn, JT | 1 |
| Goebel, J | 1 |
| Kupferman, JC | 1 |
| Warady, BA | 1 |
| Furth, SL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)[NCT00327860] | 1,100 participants (Actual) | Observational | 2003-10-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for iohexol and Hypertriglyceridemia
| Article | Year |
|---|---|
Dyslipidemia in children with chronic kidney disease.
Topics: Adolescent; Age Factors; Biomarkers; Body Mass Index; Chi-Square Distribution; Child; Child, Prescho | 2010 |